Delaware Judge Tosses Biotech Exec.'s $700M Suit Over Failed IPO
A Delaware judge dismissed a former Aurion Biotech executive's challenge to a stockholder's alleged takeover of the company, finding he failed to plausibly allege that defendants caused the…
Read the full articleYou might also wanna read
US Judge Withdraws Decision Due to AI-Like Errors in Legal Opinion
A US district court judge has withdrawn his decision in a biopharma securities case after it was found to contain fake quotes and other erro
The Verge·11mo ago
Delaware Court Dismisses $4.6 Billion KnowBe4 Buyout Lawsuit Against KKR and Elephant Partners
KKR & Co., Elephant Partners, and KnowBe4 Inc. prevailed Wednesday in litigation over the cybersecurity firm’s $4.6 billion sale to a privat
news.bloomberglaw.com·1mo ago
Amgen's PCSK9 Patent Battle: Legal Loss but Commercial Victory
In 2014, Amgen sued Sanofi and Regeneron to claim ownership of an entire class of cholesterol drugs. Nine years later, the Supreme Court rul
alexkesin.com·9mo ago
STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and more
U.S. judge blocked a Colorado state panel from placing a cap on the price of Amgen's blockbuster drug Enbrel
Elon Musk’s Bid to Set Aside Twitter Fraud Verdict Rejected by US Judge
A federal judge on Monday rejected Elon Musk’s bid to void a jury verdict finding that the world’s richest person defrauded Twitter investor
WWE-Endeavor Merger Shareholder Lawsuit Trial Canceled Days Before Scheduled Testimony
The scheduled trial in the shareholder lawsuit challenging the 2023 merger of World Wrestling Entertainment (WWE) and Endeavor has been canc
Comments
Sign in to join the conversation.
No comments yet. Be the first.